Predicting which children are at risk for ependymoma relapse

Journal of Neuro-Oncology

Volumn 78, Issue 1, 2006, Pages 41-46

  Sowar, Kristina ^a   Straessle, Jennifer ^a   Donson, Andrew M ^a   Handler, Michael ^a   Foreman, Nicholas K ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Children; Ependymoma; Gene expression; Microarray; Relapse

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN 2; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PLECKSTRIN; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BRAIN SURGERY; CANCER RECURRENCE; CANCER RELAPSE; CHILD; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA MICROARRAY; EPENDYMOMA; FEMALE; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MALE; MICROCHIP ANALYSIS; PREDICTION; PSEUDOGENE; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA EXTRACTION;

ADOLESCENT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; EPENDYMOMA; GENE EXPRESSION PROFILING; HUMANS; NEOPLASM RECURRENCE, LOCAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER;

EID: 33646886336     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-005-9072-2     Document Type: Article

References (31)

1. Korshunov A, Neben K, Wrobel G, Tews B, Benner A, Hahn M, Golanov A, Lichter P,: Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age Am J Pathol 163: 1721-1727, 2003
2. Paulino AC,: Radiotherapeutic management of intracranial ependymoma. Pediatr Hematol Oncol 19: 295-308, 2002
3. Rickert CH, Paulus W,: Epidemiology of central nervous system neoplasms in childhood and adolescence based on the new WHO classificationChilds Nerv Syst 17: 503-511, 2001
4. McLaughlin MP, Marcus RB, Buatti JM, McCollough WM, Mickle JP, Kedar A, Maria RL, Million RR,: Ependymoma: results, prognostic factors and treatment recommendationsInt J Radiat Oncol Biol Phys 40: 845-850, 1998
5. Van Veelen MLC, Pierre-Kahn A, Kalifa C, Sainte-Rose C, Zerah M, Thorne J, Renier D,: EpendPmoma in childhood: prognostic factors, extent of surgery, and adjuvant therapyJ Neurosurg 97: 827-835, 2002
6. Perilongo G, Massimino M, Sotti G, Belfontali T, Masiero L, Rigobello L, Garre L, Carli M, Lombardi F, Solero C, Sainati L, Canale V, DelPrever AB, Giangaspero F, Andreussi L, Mazza C, Madon E,: Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-Oncology GroupMed Pediatr Oncol 29: 79-85, 1997
7. Agaoglu FY, Ayan I, Dizdar Y, Kebudi R, Gorgun O, Darendeliler E,: Ependymal tumors in childhood Pediatr Blood Cancer 45: 298-303, 2005
8. Jaing T, Wang H, Tsay P, Tseng C, Jung S, Lin K, Lui T,: Multivariate analysis of clinical prognostic factors in children with intracranial ependymomasJ Neurooncol 68: 255-261, 2004
9. Hamilton RL, Pollack IF: The molecular biology of ependymomas. Brain Pathol 7: 807-822, 1997
10. Ernestus RI, Schroder R, Stutzer H, Klug N,: Prognostic relevance of localization and grading in intracranial ependymomas of childhoodChilds Nerv Syst 12: 522-526, 1996
11. Bouffet E, Perilongo G, Canete A, Massimino M,: Intracranial ependymomas in children: A critical review of prognostic factors and a plea for cooperationMed Pediatr Oncol 30: 319-331, 1998
12. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, Borresen-Dale AL,: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProc Natl Acad Sci USA 98: 10869-10874, 2001
13. Glas AM, Kersten MJ, Delahaye L, Witteveen AT, Kibbelaar RE, Velds A, Wessels LF, Joosten P, Bernards R, can Krieken J, Kluin PM, van't Veer LJ, de Jong D,: Gene expression profiling in follicular lymphomas to assess clinical aggressiveness and to guide choice of treatmentBlood 105: 301-307, 2005
14. Lee YF, John M, Falconer A, Edwards S, Clark J, Flohr P, Roe T, Wang R, Shipley J, Grimer RJ, Mangham DC, Thomas JM, Fisher C, Judson I, Cooper CS,: A gene expression signature associated with metastatic outcome in human leiomyosarcomas Cancer Res 64: 7201-7204, 2004
15. Ramaswamy S, Ross KN, Lander ES, Golub TR,: A molecular signature of metastasis in primary solid tumors Nat Genet 33: 49-54, 2003
16. Suarez-Merino B, Hubank M, Revesz T, Harkness W, Hayward R, Thompson D, Darling JL, Thomas DG, Warr TJ,: Microarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3 Neuro-oncology 7:20-31, 2005
17. Tibshirani R, Hastie T, Narasimhan B, Chu G,: Diagnosis of multiple cancer types by shrunken centroids of gene expression PNAS 99: 6567-6572, 2002
18. Lie YS, Petropoulos CJ,: Advances in quantitative PCR technology: ′5 nuclease assays Curr Opin Biotechnol 9:43-48. 1998
19. Duncan JA, Hoffman HJ,: Surgical aspects and general management of ependymomas. In: Apuzzo MLJ, (ed) Benign Cerebral Gliomas, Vol. 2. AANS, Charlottesville, pp 413-426
20. Prayson RA,: Cyclin D1 and MIB-1 immunohistochemistAy in ependymomas: a study of 41 cases. Am J Clin Pathol 110: 629-634, 1998
21. Goldwein JW, Leahy JM, Packer RJ, Sutton LN, Curran WJ, Rorke LB, Schut L, Littman PS, D'Angoio GJ,: Intracranial ependymomas in childrenInt J Radiat Oncol Biol Phys 19:1497-1502, 1990
22. Pollack IF, Gerszten PC, Martinez AJ, Lo KH, Shultz B, Albright AL, Janosky J, Deutsch M,: IntracraniLl ependymomas of childhood: long-term outcome and prognostic factors Neurosurgery 37: 655-666, 1995
23. Bennetto L, Foreman N, Harding B, Hayward R, Ironside J, Love S, Ellison D,: Ki-67 immunolabelling index is a prognostic indicator in childhood posterior fossa ependymomas Neuropathol Appl Neurobiol 24: 434-440,1998
24. Timmerman B, Kortmann RD, Kuhl J, et al.: Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German Prospective Trials HIT 88/89 and HIT 91Int J Radiat Oncol Biol Phys 46:287-295, 2000
25. Taylor RE,: Review of radiotherapy dose and volume for intracranial ependymoma. Pediatr Blood Cancer 42: 457-460, 2004
26. Viatour P, Bentires-Alj M, Chariot A, Deregowshi V, de Leval L, Merville MP, Bours V,: NF-kappa B2/p100 induces Bcl-2 expressionLeukemia 17: 1349-1356, 2003
27. Tyers M, Haslam RJ, Rachubinski RA, Harley CB,: Molecular analysis of pleckstrin: The major protein kinase C substrate of plateletsJ Cell Biochem 40: 133-145, 1989
28. Kienzle N, Young D, Silins SL, Sculley TB,: Induction of pleckstrin by the Epstein-Barr virus nuclear antigen 3 familyVirology 224: 167-174, 1996
29. Cahir-McFarland ED, Carter K, Rosenwald A, Giltnane JM, Henrickson SE, Staudt LM, Kieff E,: Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein Barr virus latency III-infected cellsJ Virol 78: 4108-4119, 2004
30. Cai XM, Tao BB, Wang LY, Liang YL, Jin JW, Yang Y, Hu YL, Zha XL: Protein phosphatase activity of PTEN inhibited the invasion of glioma cells with epidermal growth factor receptor mutation type III expression. Int J Cancer (Epub), 2005
31. Tsutsui S, Onoue H, Yasuda K, Suzuki K, Higashi H, Era S, Mori M,: Reduced expression of PTEN protein and its prognostic implications in invasive ductal carcinoma of the breast Oncology 68: 398-404, 2005